Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-014546
Filing Date
2025-02-18
Accepted
2025-02-18 08:16:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 9234
2 EXHIBIT A tm256774d1_ex99-a.htm EX-99.(A) 3321
  Complete submission text file 0001104659-25-014546.txt   14331
Mailing Address 525 WASHINGTON BLVD JERSEY CITY NJ 07310
Business Address 525 WASHINGTON BLVD JERSEY CITY NJ 07310 212-791-4663
Nukkleus Inc. (Subject) CIK: 0001787518 (see all company filings)

EIN.: 383912845 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92171 | Film No.: 25632811
SIC: 8742 Services-Management Consulting Services
(CF Office: 07 Trade & Services)

Mailing Address 211 EAST 43RD STREET, SUITE 402 NEW YORK NY 10017
Business Address 211 EAST 43RD STREET, SUITE 402 NEW YORK NY 10017 646-278-6785
Esousa Group Holdings LLC (Filed by) CIK: 0002033034 (see all company filings)

EIN.: 881214533 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SCHEDULE 13G/A